Barclays lowered the firm’s price target on Thermo Fisher to $475 from $585 and keeps an Overweight rating on the shares post the Q3 report. The company reset market expectations for 2024 of 2%-1% declines, well below expectations, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on TMO:
- Thermo Fisher downgraded to Sector Weight from Overweight at KeyBanc
- Thermo Fisher Scientific Earnings Report: Did it Beat Expectations?
- Wells ups Thermo Fisher to Equal Weight with ‘bear thesis boxes finally checked’
- Thermo Fisher upgraded to Equal Weight from Underweight at Wells Fargo
- Thermo Fisher sees FY23 adjusted EPS $21.75, consensus $26